President Trump to discuss policies boosting domestic drug production and innovation investment The White House announced plans for President Trump to meet with pharmaceutical industry
Voluntary early-review initiative shifts to preventive manufacturing quality oversight The FDA launched a new “Pre-Check” voluntary program allowing pharmaceutical manufacturers to undergo proactive quality systems
Senior credit facility supports Afrezza pediatric launch, commercial expansion, and pipeline advancement MannKind Corporation secured up to $500 million in a senior credit facility from
Inflammatory disease biotech pursues unprecedented combination of drug development and Ethereum treasury management In an unusual move for biotechnology, 180 Life Sciences announced a massive
Inflammatory disease biotech pursues unprecedented combination of drug development and Ethereum treasury management In an unusual move for biotechnology, 180 Life Sciences announced a massive
Series B funding supports programmable mRNA platform with lead candidate showing promise in solid tumors Massachusetts-based Strand Therapeutics completed a $153 million Series B financing
Multi-year partnership leverages AI analytics to improve treatment outcome modeling AstraZeneca expanded its collaboration with health data firm SOPHiA GENETICS to harness AI-powered “Multimodal Analytics
Exclusive U.S. licensing deal aims to reshape colorectal cancer screening landscape Exact Sciences secured exclusive U.S. commercialization rights to Freenome’s blood-based colorectal cancer screening test
Belgian specialty pharma gains pediatric cancer franchise and FDA priority review voucher Belgian specialty pharmaceutical company SERB Pharmaceuticals announced an all-cash $412 million acquisition of
Vepdegestrant PROTAC estrogen receptor degrader targets ER+ breast cancer with novel mechanism The FDA accepted Arvinas and Pfizer’s New Drug Application for vepdegestrant (ARV-471), granting
